![Richard W. Thomas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard W. Thomas
Director/Board Member at EpiWatch, Inc.
Richard W. Thomas active positions
Companies | Position | Start | End |
---|---|---|---|
EpiWatch, Inc.
![]() EpiWatch, Inc. Internet Software/ServicesTechnology Services EpiWatch, Inc. is a company founded by Nathan Crone and Gregory professors of neurology and epileptologists at the Johns Hopkins School of Medicine. The company is based in Baltimore, MD and uses technology licensed from Johns Hopkins. EpiWatch aims to lead the digital transformation of epilepsy care by delivering innovative and integrated services that keep people with epilepsy safe, enable them, their caregivers, and their physicians to better manage their condition, and provide peace of mind for their loved ones. The company is initially developing a proprietary capability to detect and alert for potentially dangerous tonic-clonic (grand mal) seizures. EpiWatch is leading the digital transformation of epilepsy care by delivering innovative and integrated services that keep people with epilepsy safe, enable them, their caregivers, and their physicians to better manage their condition. Dean Papadopoulos has been the CEO of the company since 2020. | Director/Board Member | 2022-04-06 | - |
Career history of Richard W. Thomas
Former positions of Richard W. Thomas
Companies | Position | Start | End |
---|---|---|---|
Defense Health Agency | Chief Tech/Sci/R&D Officer | - | - |
Statistics
International
United States | 2 |
2 |
Operational
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Technology Services | 2 |
Government | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
EpiWatch, Inc.
![]() EpiWatch, Inc. Internet Software/ServicesTechnology Services EpiWatch, Inc. is a company founded by Nathan Crone and Gregory professors of neurology and epileptologists at the Johns Hopkins School of Medicine. The company is based in Baltimore, MD and uses technology licensed from Johns Hopkins. EpiWatch aims to lead the digital transformation of epilepsy care by delivering innovative and integrated services that keep people with epilepsy safe, enable them, their caregivers, and their physicians to better manage their condition, and provide peace of mind for their loved ones. The company is initially developing a proprietary capability to detect and alert for potentially dangerous tonic-clonic (grand mal) seizures. EpiWatch is leading the digital transformation of epilepsy care by delivering innovative and integrated services that keep people with epilepsy safe, enable them, their caregivers, and their physicians to better manage their condition. Dean Papadopoulos has been the CEO of the company since 2020. | Technology Services |
Defense Health Agency | Government |
- Stock Market
- Insiders
- Richard W. Thomas
- Experience